-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on DexCom, Raises Price Target to $95

Benzinga·07/31/2026 17:49:54
语音播报
Mizuho analyst Anthony Petrone maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $95.